CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

no intervention. observational cohort studyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1673 Magnetic Resonance Imaging Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Seroprevalence and Immunoprotection Against SARS-CoV2 in Children Hospitalized in Paris

The paediatric population present mild or asymptomatic form of SARS-CoV-2 infection. This study asses the frequency of patients with SARS-CoV2 Antibodies (Ab) (seroprevalence) and the neutralizing typology of those Ab (immunoprotection) in children from 7 days to 18 years of age hospitalized for no more than 4 days and whose clinical status requires blood sample regardless of the symptoms Patients are included on a given day, after information, before blood sampling performed as part of the care. 500 µL of sera, normally discarded will be kept to perform SARS-Cov2 serology.

NCT04490811 COVID-19 Other: no intervention. observational cohort study

Primary Outcomes

Description: Ab against SARS-CoV-2

Measure: serological test

Time: 48 weeks

Secondary Outcomes

Description: activity of the antibodies against SARS-CoV2

Measure: neutralizing Ab

Time: 48 weeks

Description: Lymphocyte response phenotyping

Measure: Immuno phenotyping

Time: 48 weeks

No related HPO nodes (Using clinical trials)